Abstract:MicroRNAs (miRNAs) are small, single-stranded, noncoding RNAs that can post-transcriptionally regulate the expression of various oncogenes and tumor suppressor genes. Dysregulated expression of many miRNAs have been shown to mediate the signaling pathways critical in the multistep carcinogenesis of colorectal cancer (CRC). MiRNAs are stable and protected from RNase-mediated degradation, thereby enabling its detection in biological fluids and archival tissues for biomarker studies. This review focuses on the role and application of miRNAs in the prognosis and therapy of CRC. While stage II CRC is potentially curable by surgical resection, a significant percentage of stage II CRC patients do develop recurrence. MiRNA biomarkers may be used to stratify such high-risk population for adjuvant chemotherapy to provide better prognoses. Growing evidence also suggests that miRNAs are involved in the metastatic process of CRC. Certain of these miRNAs may thus be used as prognostic biomarkers to identify patients more likely to have micro-metastasis, who could be monitored more closely after surgery and/or given more aggressive adjuvant chemotherapy. Intrinsic and acquired resistance to chemotherapy severely hinders successful chemotherapy in CRC treatment. Predictive miRNA biomarkers for response to chemotherapy may identify patients who will benefit the most from a particular regimen and also spare the patients from unnecessary side effects. Selection of patients to receive the new targeted therapy is becoming possible with the use of predictive miRNA biomarkers. Lastly, forced expression of tumor suppressor miRNA or silencing of oncogenic miRNA in tumors by gene therapy can also be adopted to treat CRC alone or in combination with other chemotherapeutic drugs.

Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer

Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

MicroRNAs targeting EGFR signalling pathway in colorectal cancer

MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer

Advances in microRNAs as Emerging Biomarkers for Colorectal Cancer Early Detection and Diagnosis

Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions

MicroRNAs and ‘Sponging’ Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets

Exploring the Gut Microbiome’s Role in Colorectal Cancer: Diagnostic and Prognostic Implications

Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives

MicroRNAs as biomarkers for colorectal cancer: recent advances

MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer

MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications

MicroRNAs in colorectal cancer: Small molecules with big functions

Gut microbiota in colorectal cancer development and therapy

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer

MicroRNAs in colorectal carcinoma--from pathogenesis to therapy

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer

Gut Microbiota Signatures in Colorectal Cancer as a Potential Diagnostic Biomarker in the Future: A Systematic Review